MA26758A1 - NEW, MODIFIED RELEASE COMPOSITION FOR THE TREATMENT OF DIABETES. - Google Patents

NEW, MODIFIED RELEASE COMPOSITION FOR THE TREATMENT OF DIABETES.

Info

Publication number
MA26758A1
MA26758A1 MA26192A MA26192A MA26758A1 MA 26758 A1 MA26758 A1 MA 26758A1 MA 26192 A MA26192 A MA 26192A MA 26192 A MA26192 A MA 26192A MA 26758 A1 MA26758 A1 MA 26758A1
Authority
MA
Morocco
Prior art keywords
diabetes
treatment
new
release composition
modified release
Prior art date
Application number
MA26192A
Other languages
French (fr)
Inventor
Karen Lewis
Nicola Jayne Lilliott
Donald Colin Mackenzie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA26758A1 publication Critical patent/MA26758A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"Composition nouvelle, à libération modifiée, pour le traitement du diabète" L'invention concerne une composition pharmaceutique à libération modifiée. Cette composition comprend un sensibilisant à l'insuline, un autre agent antidiabétique et un support pharmaceutiquement acceptable. Application : utilisation de cette composition pour le traitement du diabète."Novel, modified-release composition for the treatment of diabetes" The invention relates to a modified-release pharmaceutical composition. This composition includes an insulin sensitizer, another anti-diabetic agent and a pharmaceutically acceptable carrier. Application: use of this composition for the treatment of diabetes.

MA26192A 1998-11-12 2001-05-11 NEW, MODIFIED RELEASE COMPOSITION FOR THE TREATMENT OF DIABETES. MA26758A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9824866.9A GB9824866D0 (en) 1998-11-12 1998-11-12 Novel composition and use

Publications (1)

Publication Number Publication Date
MA26758A1 true MA26758A1 (en) 2004-12-20

Family

ID=10842370

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26192A MA26758A1 (en) 1998-11-12 2001-05-11 NEW, MODIFIED RELEASE COMPOSITION FOR THE TREATMENT OF DIABETES.

Country Status (5)

Country Link
CN (1) CN1762494A (en)
CO (1) CO5150180A1 (en)
GB (1) GB9824866D0 (en)
MA (1) MA26758A1 (en)
ZA (1) ZA200103843B (en)

Also Published As

Publication number Publication date
ZA200103843B (en) 2002-05-14
GB9824866D0 (en) 1999-01-06
CO5150180A1 (en) 2002-04-29
CN1762494A (en) 2006-04-26

Similar Documents

Publication Publication Date Title
TNSN98211A1 (en) COMBINATION OF AN ALDOSE-REDUCTASE INHIBITOR AND A GLYCOGENE-PHOSPHORYLASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
TNSN98017A1 (en) SULFONYLUREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DZ2936A1 (en) New modified release composition for the treatment of diabetes.
BR0007500A (en) Triazole compound, drug, and, use of the compound
TNSN99053A1 (en) ACID HYDROXAMIDES (4-ARYLSULFONYLAMINO) -TETRAHYDRO- PYRANNE-4-CARBOXYLIQUES), PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
MA26728A1 (en) PHARMACEUTICAL COMPOSITION COMPRISING A CYP2D6 INHIBITOR AND A CYP2D6 CATALYZED METABOLISM DRUG
DZ2520A1 (en) Pharmaceutical composition for a method of treating diabetes mellitus.
TNSN96104A1 (en) (1S, 2S) -1- (4-HYDROXYPHENYL) -2- (4-HYDROXY-4-PHENYLPIPERIDINE-1-YL) -1-PROPANOL TRIHYDRATE METAHENSULFONATE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
PT958296E (en) HETEROCYCLIC COMPOUNDS PROCESS FOR THEIR PREPARATION PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND ITS UTILIZATION IN THE TREATMENT OF RELATED DIABETES AND DISEASES
MX9708621A (en) 'beta'-ADRENERGIC AGONISTS.
TNSN99006A1 (en) 4- (2-CETO-1-BENZIMIDAZOLINYL) NOVEL PIPERIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN96072A1 (en) N- (INDOLE -2-CARBONYL) -GLYCINAMIDES SUBSTITUTED, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
BR0114410A (en) Combination of a cb1 receptor antagonist and sibutramine, the pharmaceutical compositions containing them and their use for the treatment of obesity
NO993646D0 (en) Thiazole benzenesulfonamides as <beta> 3 agonists for the treatment of diabetes and obesity
DE59609926D1 (en) STABILIZED THYROID HORMONE DRUGS
TNSN98182A1 (en) NOVEL PROSTAGLANDIN AGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT741716E (en) ANALOGOS OF DELTA 12,13-ISO-TAXOL ITS ANTI-NEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
TR200101961T2 (en) 1,2-ring quinoline derivatives
BR9609653A (en) Pharmaceutical compounds and compositions containing the same
DZ2539A1 (en) Pharmaceutical compositions for the treatment of insulin resistance.
BR9909138A (en) Combination for the treatment of alcohol and drug addiction containing an opioid antagonist and a nmda receptor complex modulator
ES2124905T3 (en) ANTIGLUCOCORTICOID STEROIDS INTENDED FOR THE TREATMENT OF ANXIETY DISORDERS.
BR0011928A (en) Compound, pharmaceutical composition, use of, a compound and methods for the treatment of diabetic complications, for the treatment or prevention of the development of disease conditions associated with impaired neuronal conduction velocity and diabetic neuropathy
TR199800521T1 (en) Seimli beta3 adrenerjik agonistler.
GB2331988A9 (en) Polycyclic sulphamate inhabitors of oestrone sulphatase